Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2018 Filed May 29, 2018 21:06 UTC |
Melincoff Gwen ADirector
|
GrantStock Option (Right to Purchase) · Derivative | 4,506 | $0.00 Strike: $24.95 | $0.00 |
DisclosureSEC source: 0001192482-18-000254 · edgar.xml · derivative · entry 2 Melincoff Gwen A · CIK 0001614890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,506 Underlying: Common Stock · 4,506 shares Expires 2028-05-24 F2 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:06 UTC |
Melincoff Gwen ADirector
|
GrantCommon Stock | 2,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000254 · edgar.xml · nonDerivative · entry 1 Melincoff Gwen A · CIK 0001614890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,253 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:05 UTC |
BOHLIN GAREN GDirector
|
GrantStock Option (Right to Purchase) · Derivative | 4,506 | $0.00 Strike: $24.95 | $0.00 |
DisclosureSEC source: 0001192482-18-000253 · edgar.xml · derivative · entry 2 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,506 Underlying: Common Stock · 4,506 shares Expires 2028-05-24 F2 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:05 UTC |
BOHLIN GAREN GDirector
|
GrantCommon Stock | 2,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000253 · edgar.xml · nonDerivative · entry 1 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,253 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:02 UTC |
Hirsch DavidDirector
|
GrantStock Option (Right to Purchase) · Derivative | 4,506 | $0.00 Strike: $24.95 | $0.00 |
DisclosureSEC source: 0001192482-18-000251 · edgar.xml · derivative · entry 4 Hirsch David · CIK 0001619884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,506 Underlying: Common Stock · 4,506 shares Expires 2028-05-24 F6 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:02 UTC |
Hirsch DavidDirector
|
GrantCommon Stock | 2,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000251 · edgar.xml · nonDerivative · entry 1 Hirsch David · CIK 0001619884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,193 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock. F2 · balance_after: Includes 24,940 shares received in distributions from Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"). Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:32 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
SaleCommon Stock | 1,500 | $27.00 | $40,500.00 |
DisclosureSEC source: 0001192482-18-000202 · edgar.xml · nonDerivative · entry 2 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,693 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended. Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:32 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
SaleCommon Stock | 5,600 | $26.00 | $145,600.00 |
DisclosureSEC source: 0001192482-18-000202 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,193 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended. Read SEC document |
| May 10, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
SaleCommon Stock | 1,400 | $27.00 | $37,800.00 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 11 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,764 F3 · kind: The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2018. Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 21:05 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
SaleCommon Stock | 100 | $26.01 | $2,601.00 |
DisclosureSEC source: 0001192482-18-000165 · edgar.xml · nonDerivative · entry 2 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,793 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended. Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 21:05 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
SaleCommon Stock | 44,300 | $26.00 | $1,151,800.00 |
DisclosureSEC source: 0001192482-18-000165 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,893 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended. Read SEC document |
| April 04, 2018 Filed Apr 5, 2018 17:00 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
GrantStock Option (Right to Purchase) · Derivative | 40,000 | $0.00 Strike: $24.03 | $0.00 |
DisclosureSEC source: 0001192482-18-000154 · edgar.xml · derivative · entry 2 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-04-04 F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on March 16, 2019, and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| April 04, 2018 Filed Apr 5, 2018 17:00 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000154 · edgar.xml · nonDerivative · entry 1 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on March 16, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:50 UTC |
Fleming Alison BChief Technology Officer
|
Exercise / conversionStock option (right to purchase) · Derivative | 3,917 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001192482-18-000151 · edgar.xml · derivative · entry 4 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,917 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 3,917 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vested and became exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vested in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:50 UTC |
Fleming Alison BChief Technology Officer
|
Exercise / conversionStock option (right to purchase) · Derivative | 4,225 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001192482-18-000151 · edgar.xml · derivative · entry 3 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,225 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 4,225 option shares are exercisable. The option, initially representing a right to purchase a total of 15,623 shares, vested and became exercisable in equal installments (rounded up to the nearest whole share of common stock) on a monthly basis over a four-year period commencing on March 5, 2014, subject to the reporting person's continued service with the issuer. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:50 UTC |
Fleming Alison BChief Technology Officer
|
Exercise / conversionCommon Stock | 3,917 | $0.28 | $1,096.76 |
DisclosureSEC source: 0001192482-18-000151 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:50 UTC |
Fleming Alison BChief Technology Officer
|
Exercise / conversionCommon Stock | 4,225 | $0.28 | $1,183.00 |
DisclosureSEC source: 0001192482-18-000151 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 23:58 UTC |
Freund John GordonDirector
|
OtherCommon Stock | 8,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000131 · edgar.xml · nonDerivative · entry 2 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By John Freund Family Partnership IV, L.P. Disclosed balance after: 20,506 F3 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to the reporting person. F4 · ownership.nature: The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 23:58 UTC |
Freund John GordonDirector
|
OtherCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000131 · edgar.xml · nonDerivative · entry 1 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P. Disclosed balance after: 1,549,916 F1 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to its limited and general partners. F2 · ownership.nature: The shares are held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC. Dr. Freund disclaims beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 16:03 UTC |
Fleming Alison BChief Technology Officer
|
Tax withholdingCommon Stock | 1,193 | $21.77 | $25,971.61 |
DisclosureSEC source: 0001192482-18-000097 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,316 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 21:04 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 4,050 | $21.77 | $88,168.50 |
DisclosureSEC source: 0001192482-18-000099 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,193 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 21:03 UTC |
Brannelly PaulExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 1,197 | $21.77 | $26,058.69 |
DisclosureSEC source: 0001192482-18-000098 · edgar.xml · nonDerivative · entry 1 Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,436 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 16:16 UTC |
Fleming Alison BChief Technology Officer
|
Tax withholdingCommon Stock | 214 | $23.38 | $5,003.32 |
DisclosureSEC source: 0001192482-18-000076 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,509 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 21:14 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 788 | $23.38 | $18,423.44 |
DisclosureSEC source: 0001192482-18-000074 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,243 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 21:18 UTC |
Brannelly PaulExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 214 | $23.38 | $5,003.32 |
DisclosureSEC source: 0001192482-18-000078 · edgar.xml · nonDerivative · entry 1 Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,633 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 00:41 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
GrantCommon Stock | 1,044 | $10.17 | $10,617.48 |
DisclosureSEC source: 0001192482-18-000067 · edgar.xml · nonDerivative · entry 2 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 595,031 F2 · kind: These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 00:38 UTC |
Brannelly PaulExecutive Vice President & CFO
|
GrantCommon Stock | 1,044 | $10.17 | $10,617.48 |
DisclosureSEC source: 0001192482-18-000063 · edgar.xml · nonDerivative · entry 3 Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,847 F2 · kind: These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 19:37 UTC |
Fleming Alison BChief Technology Officer
|
GrantStock Option (Right to Purchase) · Derivative | 50,000 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001192482-18-000061 · edgar.xml · derivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-01-25 F2 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 19:37 UTC |
Fleming Alison BChief Technology Officer
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000061 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,723 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock. Read SEC document |
| January 25, 2018 Filed Jan 30, 2018 00:41 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
GrantStock Option (Right to Purchase) · Derivative | 150,000 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001192482-18-000067 · edgar.xml · derivative · entry 3 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-01-25 F3 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| January 25, 2018 Filed Jan 30, 2018 00:41 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000067 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 593,987 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock. Read SEC document |
| January 25, 2018 Filed Jan 30, 2018 00:39 UTC |
Ciaffoni JosephChief Operating Officer
|
GrantStock Option (Right to Purchase) · Derivative | 50,000 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001192482-18-000065 · edgar.xml · derivative · entry 2 Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-01-25 F2 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| January 25, 2018 Filed Jan 30, 2018 00:39 UTC |
Ciaffoni JosephChief Operating Officer
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000065 · edgar.xml · nonDerivative · entry 1 Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,268 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock. Read SEC document |
| January 25, 2018 Filed Jan 30, 2018 00:38 UTC |
Brannelly PaulExecutive Vice President & CFO
|
GrantStock Option (Right to Purchase) · Derivative | 50,000 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001192482-18-000063 · edgar.xml · derivative · entry 4 Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-01-25 F3 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| January 25, 2018 Filed Jan 30, 2018 00:38 UTC |
Brannelly PaulExecutive Vice President & CFO
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000063 · edgar.xml · nonDerivative · entry 2 Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,803 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock. Read SEC document |
| January 23, 2018 Filed Jan 23, 2018 22:41 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
SaleCommn Stock | 16,408 | $25.01 | $410,364.08 |
DisclosureSEC source: 0001192482-18-000054 · edgar.xml · nonDerivative · entry 2 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518,987 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2018 Filed Jan 23, 2018 22:41 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
SaleCommon Stock | 3,592 | $25.00 | $89,800.00 |
DisclosureSEC source: 0001192482-18-000054 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,395 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended. Read SEC document |
| January 19, 2018 Filed Jan 19, 2018 22:41 UTC |
Heffernan Michael ThomasDirector · Chairman, President and CEO
|
SaleCommon Stock | 20,000 | $22.50 | $450,000.00 |
DisclosureSEC source: 0001192482-18-000046 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,987 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.50 to $22.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 19, 2018 Filed Jan 11, 2021 17:06 UTC |
Fleming Alison BChief Technology Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 3,336 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0001192482-21-000050 · edgar.xml · derivative · entry 5 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,042 Underlying: Common Stock · 3,336 shares Expires 2025-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: At the time of exercise, 3,336 shares under the option were exercisable. The option, initially representing a right to purchase a total of 60,378 shares, vested and became exercisable over a four-year period commencing on March 19, 2015. The option vested and became exercisable in equal installments (rounded up to the nearest whole share) on a monthly basis over a four-year period commencing on March 19, 2015, subject to the employee's continued service with the issuer. Read SEC document |
| January 19, 2018 Filed Jan 11, 2021 17:06 UTC |
Fleming Alison BChief Technology Officer
|
SaleCommon Stock | 3,336 | $23.00 | $76,728.00 |
DisclosureSEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,419 F2 · kind: The sales occurring on January 19, 2018 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017. Read SEC document |
| January 19, 2018 Filed Jan 11, 2021 17:06 UTC |
Fleming Alison BChief Technology Officer
|
Exercise / conversionCommon Stock | 3,336 | $5.73 | $19,115.28 |
DisclosureSEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The transactions reported in this Form 4 occurring on January 19, 2018 are late due to an administrative error. Read SEC document |
| January 19, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 1,449 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · derivative · entry 17 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,449 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option was fully vested and exercisable as of January 19, 2018. Read SEC document |
| January 19, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 1,811 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · derivative · entry 16 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,811 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option was fully vested and exercisable as of January 19, 2018. Read SEC document |
| January 19, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 64 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · derivative · entry 15 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64 shares Expires 2019-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option was fully vested and exercisable as of January 19, 2018. Read SEC document |
| January 19, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
SaleCommon Stock | 1,449 | $23.00 | $33,327.00 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 10 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,164 F2 · kind: The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017. Read SEC document |
| January 19, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
Exercise / conversionCommon Stock | 1,449 | $3.31 | $4,796.19 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 9 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
SaleCommon Stock | 1,811 | $23.00 | $41,653.00 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 8 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,164 F2 · kind: The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017. Read SEC document |
| January 19, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
Exercise / conversionCommon Stock | 1,811 | $0.90 | $1,629.90 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 7 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
SaleCommon Stock | 64 | $23.00 | $1,472.00 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 6 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,164 F2 · kind: The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017. Read SEC document |
| January 19, 2018 Filed Mar 3, 2021 20:01 UTC |
Fleming Alison BChief Technical Officer
|
Exercise / conversionCommon Stock | 64 | $0.90 | $57.60 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 5 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.